Mercado Global de Insuficiência Renal Aguda (ARF) – Tendências do setor e previsão para 2028

Análise de mercado e insights: mercado global de insuficiência renal aguda (ARF)

Espera-se que o mercado da insuficiência renal aguda (ARF) ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 5,10% no período de previsão de pesquisa acima referido. Aumento da população geriátrica e aumento da carga de insuficiência renal aguda, entre outros.  

O aumento da população obesa e diabética e o aumento da incidência de dengue, malária e leptospirose também impulsionam o crescimento do mercado. Além disso, o aumento da investigação e desenvolvimento, a presença de medicamentos em pipeline e o aumento dos gastos em saúde funcionam como uma oportunidade para o crescimento do mercado. Mas, por vezes, os efeitos adversos causados ​​pelos medicamentos, a falta de coordenação do cuidador e o quadro regulamentar rigoroso para a aprovação dos medicamentos podem dificultar o mercado global da insuficiência renal aguda (IRA).

Acute renal failure (ARF) is characterized by the sudden loss of kidney ability to eliminate the excess of fluid, metabolic waste and salts from the body. This inability leads to accumulation of electrolytes and metabolic wastes in the body that leads to life-threatening issues. Acute kidney failure develops in less interval of time and has been reported mostly to affect the people who are already hospitalized especially in people who rely on intensive care. The most common symptom associated with ARF includes decrease urine output, fluid retention, fatigue, confusion, nausea, weakness, irregular heartbeat, chest pain, seizures among others. Primarily acute renal failure is prerenal, postrenal and intrarenal failure. Prerenal failure commonly arises due to depletion of intravascular volume, intrarenal arises due to tubules damage while postrenal is most commonly associated with obstruction of tracks. Moreover severe dehydration, autoimmune diseases, medication toxicity can also lead to ARF. Acute renal failure can be treated by balancing of body fluids, calcium supplements, potassium supplements and dialysis.

According to the publication of National Kidney Foundation Inc. over 2 million people worldwide receiving kidney associated disease treatment with either dialysis and kidney transplant. As the kidney affected people rising worldwide, they demands effective treatment and therapies hence expected to provide market with the lucrative growth.

This acute renal failure (ARF) market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Acute Renal Failure (ARF) Market Scope and Market Size

Acute renal failure (ARF) market is segmented on the basis of type, diagnosis, treatment, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the acute renal failure (ARF) market is segmented into prerenal, intrarenal, postrenal.
• On the basis of diagnosis, the acute renal failure (ARF) market is segmented into CT scan, kidney biopsy, ultrasound.
• On the basis of treatment, the acute renal failure (ARF) market is segmented into medications and dialysis. Medication segment is further sub-segmented into sodium bicarbonates, N-acetyl cysteine, statins, others.
• On the basis of end-users, the acute renal failure (ARF) market is segmented into clinics, hospitals, home healthcare, others.
• On the basis of distribution channel, the acute renal failure (ARF) market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. 

Acute renal failure (ARF) Market Country Level Analysis

Acute renal failure (ARF) market is analysed and market size information is provided by country, type, diagnosis, treatment, end-users and distribution channel as referenced above.

The countries covered in the Acute renal failure (ARF) market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to the high awareness among the patients regarding disease symptoms and its treatment options and presence of major market players. Europe accounts the second largest market share due to due to high penetration of market players by taking strategic initiatives for enhancing their distribution channel. Asia-Pacific is expected to account for the largest market share over coming years for the acute renal failure (ARF) market due to increasing demand of effective treatment solutions and rising patient population.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

O mercado da insuficiência renal aguda (IRA) também fornece análises de mercado detalhadas para análise de doentes, prognóstico e curas. Prevalência, incidência, mortalidade, taxas de adesão são algumas das variáveis ​​de dados disponíveis no relatório. As análises de impacto direto ou indireto da epidemiologia para o crescimento do mercado são analisadas para criar um modelo estatístico multivariado mais robusto e de coorte para prever o mercado no período de crescimento.

Análise do cenário competitivo e da quota de mercado da insuficiência renal aguda (ARF)

O panorama competitivo do mercado de Insuficiência renal aguda (IRA) fornece detalhes por concorrente. os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos , pipelines de ensaios clínicos, aprovações de produtos, patentes, largura e amplitude do produto, domínio da aplicação, curva de segurança da tecnologia. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado da Insuficiência renal aguda (IRA).

Os principais players abrangidos no mercado da Insuficiência renal aguda (IRA) são Alloksys, Angion, Quark, AM-Pharma BV, Atox Bio, Astellas Pharma Inc., Pharming, MediBeacon, Exponential Biotherapies, Sequens, Pfizer Inc., Solvay, Leisha Pharma Solutions Unip. Ltd., Merck KGaA, Wacker Chemie AG, Hetero Healthcare Limited., Zydus Cadila, Dr. Reddy’s Laboratories, Novartis AG, Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceutical Inc, entre outros players nacionais e globais. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-60279